HSBC Holdings’s Alaunos Therapeutics TCRT Stock Holding History

HSBC Holdings’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-86	Closed	-$35K	–	3166
2021 Q2	$35K	Buy	+86	New	+$40.1K	﹤0.01%	2896
2021 Q1	–	Sell	-131	Closed	-$50K	–	3120
2020 Q4	$50K	Buy	+131	New	+$52.1K	﹤0.01%	2987
2020 Q3	–	Sell	-78	Closed	-$38K	–	2853
2020 Q2	$38K	Sell	78 -9	-10%	-$4.01K	﹤0.01%	2593
2020 Q1	$31K	Buy	+87	New	+$45K	﹤0.01%	2598
2017 Q1	–	Sell	-140	Closed	-$112K	–	2559
2016 Q4	$112K	Buy	+140	New	+$126K	﹤0.01%	2609

Other funds holding TCRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HSBC Holdings's TCRT Position: Q3 2021 in Review

HSBC Holdings sold out of Alaunos Therapeutics (TCRT) in Q3 2021, closing a stake of 86 shares — an estimated $35K sold.

HSBC Holdings first reported a position in TCRT in Q4 2016 and held it in 5 quarters. The position peaked at $112K in Q4 2016. 162 funds tracked by Wall St. Rank hold TCRT as of Q3 2021.

HSBC Holdings reported no remaining Alaunos Therapeutics position as of Q3 2021 after selling out during the quarter.
HSBC Holdings sold 86 Alaunos Therapeutics shares in Q3 2021, an estimated $35K.
HSBC Holdings first reported a position in Alaunos Therapeutics in Q4 2016 and held it in 5 quarters.
HSBC Holdings's Alaunos Therapeutics position peaked at $112K in Q4 2016.
162 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2021.

Based on HSBC Holdings's 13F filing for Q3 2021, filed 12 Nov 2021.